Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
226M
-
Number of holders
-
895
-
Total 13F shares, excl. options
-
226M
-
Shares change
-
-1.21M
-
Total reported value, excl. options
-
$50.8B
-
Value change
-
-$173M
-
Put/Call ratio
-
1.47
-
Number of buys
-
343
-
Number of sells
-
-416
-
Price
-
$225.01
Significant Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q4 2017
998 filings reported holding ELV - Elevance Health, Inc. - Common Stock as of Q4 2017.
Elevance Health, Inc. - Common Stock (ELV) has 895 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 226M shares
.
Largest 10 shareholders include BlackRock Inc. (22M shares), Vanguard Group Inc (17.8M shares), PRICE T ROWE ASSOCIATES INC /MD/ (16.9M shares), STATE STREET CORP (10.9M shares), FMR LLC (9.39M shares), BAILLIE GIFFORD & CO (4.88M shares), Invesco Ltd. (3.95M shares), WELLINGTON MANAGEMENT GROUP LLP (3.91M shares), NORDEA INVESTMENT MANAGEMENT AB (3.72M shares), and AQR CAPITAL MANAGEMENT LLC (3.46M shares).
This table shows the top 895 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.